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PHS98  
HEALTH CARE UTILIZATION AND COSTS ASSOCIATED WITH COMORBID 
OBESITY IN ADULTS WITH TYPE 2 DIABETES MELLITUS FROM A NATIONALLY 
REPRESENTATIVE US POPULATION  
Chuang CC1, Chen SY1, Lee E2, Sullivan PW3 
1United BioSource Corporation, Lexington, MA, USA, 2Boehringer Ingelheim Pharmaceuticals, Inc., 
Ridgefield, CT, USA, 3Regis University School of Pharmacy, Denver, CO, USA  
OBJECTIVES: To assess health care resource utilization (HRU) and costs asso-
ciated with comorbid obesity in patients with type 2 diabetes mellitus (T2DM) 
from a nationally representative US sample. METHODS: The 2009 Medical 
Expenditure Panel Survey was analyzed to identify adults (≥20 years) with 
diabetes (ICD-9-CM: 250). T2DM was identified if one of the following criteria was 
met: 1) evidence of ≥1 oral or non-insulin injectable anti-diabetic medication; 2) 
diagnosis of diabetes after age 30; 3) diagnosis before age 30 and not on insulin 
monotherapy. Pregnant women were excluded. Annual HRU and costs were 
compared for individuals with T2DM based on the presence of comorbid obesity 
(BMI≥30 kg/m2). A generalized linear regression model adjusting for patient 
demographic and clinical characteristics was performed to assess the association 
between comorbid obesity and total health care costs. Population weights were 
applied to account for the multi-stage sampling design to produce nationally 
representative estimates. RESULTS: Of the 2,269 T2DM patients (representing 
19.2 million individuals in the US), 54.5% were obese. Obese T2DM patients were 
more likely to be younger (59 vs. 65 years; p<0.01) than non-obese T2DM patients. 
Obese T2DM patients had similar inpatient hospital (17.8% vs. 17.9%; p=0.99) and 
emergency room (21.7% vs. 19.5%; p=0.33) utilization but utilized more outpatient 
hospital visits (33.3% vs. 27.9%; p=0.03), had more prescription medication fills 
(48.0 vs. 37.1, p<0.01) and higher total health care costs ($12,009 vs. $10,081, 
p=0.02) than non-obese T2DM patients. After controlling for age, gender, race, 
income, insured status and comorbidities, obese T2DM patients had total health 
care costs of 1.19 times those of the non-obese T2DM patients (p=0.04). 
CONCLUSIONS: Obesity appears to be associated with higher health care costs in 
T2DM patients. Effective weight management in T2DM patients may be cost-
effective and should be considered in diabetes treatment plans.  
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TO IDENTIFY COMORBID DEPRESSION IN DIABETES PATIENTS AND 
COMPARING THE DIFFERENCES IN USE OF HEALTH CARE SERVICES IN 
DIABETIC PATIENTS WITH AND WITHOUT COMORBID DEPRESSION  
Rege S1, Quilliam BJ2 
1University of Rhode Island, Kingston, RI, USA, 2University of Rhode Island, Kingston, RI, USA  
OBJECTIVES: To assess the effect of comorbid depression on rates of health care 
resource utilization in patients with diabetes. METHODS: We carried out a 
secondary analysis of data from 2008 Medical Expenditure Panel Survey for the 
year. In contrast to previous research, we identified diabetes and comorbid 
depression among the adult population by using their self-report. People with 
diabetes were identified by examining their self report regarding a diabetes 
diagnosis. We identified patients with diagnosed and undiagnosed depression by 
using a score of ≥3 on the two-item Patient Health Questionnaire. This unique 
method of identifying depression has been validated elsewhere. We calculated 
odds ratios for having depression in respondents with and without diabetes 
adjusting for demographic factors. We compared the mean unadjusted health 
care utilization rates in the diabetic people with and without depression. We also 
assessed the factors that were associated with incidence of comorbid diabetes 
and the use of health care services. RESULTS: In the year 2008, 2381 respon-
dents suffered from diabetes while 400 respondents suffered from comorbid 
depression. Diabetics were more likely than non-diabetics to suffer from 
depression (Adjusted OR 1.20, 95% CI 1.05–1.37). People suffering from this 
comorbidity were more likely to be females, married, Hispanic and have a lower 
poor income level. The mean emergency room visits (0.90 vs. 0.41 p<0.001), the 
mean outpatient visits (19.62 vs. 16.22 p<0.001) and the mean office based visits 
(215.1 vs. 159.3 p=0.003) were higher in diabetic patients with depression. In the 
adjusted analyses, depression was associated with an increase in the use of 
health care resources. CONCLUSIONS: Utilizing a unique way to identify diabetes 
and depression in the general population, we found that the likelihood of 
suffering from depression is higher in case of diabetics. Comorbid diabetes and 
depression is associated with higher use of health services.  
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REDUCING TOTAL HEALTH CARE COSTS BY SHIFTING TO OUTPATIENT (OP) 
SETTINGS OF CARE FOR THE MANAGEMENT OF GRAM+ ACUTE BACTERIAL 
SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI)  
Khachatryan A1, Ektare V1, Xue M1, Dunne M2, Johnson KE3, Stephens JM1 
1Pharmerit International, Bethesda, MD, USA, 2Durata Therapeutics, Branford, CT, USA, 3Durata 
Therapeutics, Chicago, IL, USA  
OBJECTIVES: Rising health care costs and financial penalties have necessitated 
treatment strategies for ABSSSI that avoid hospital admissions and reduce 
length of stay (LOS), hospital acquired infections (HAIs), and readmissions. 
Providing parenteral antibiotic therapy in OP settings provides an opportunity to 
shift care outside the hospital to free hospital beds and reduce additional LOS 
from HAIs. This analysis estimated, from a US payer perspective, cost offsets of 
treating gram+ ABSSSIs with varied hospital LOS followed by OP care. METHODS: 
Economic drivers of care were estimated using a literature-based economic 
model incorporating inpatient (IP) and OP components. The model incorporated 
equal efficacy, adverse events (AE), resource use, and costs from literature and 
public sources. Once and twice daily OP infusions to achieve a 14-day treatment 
were tested to determine cost offsets shifting IP days to OP days. Sensitivity 
analyses were performed. Costs were adjusted to 2012US$. RESULTS: Total non-
drug medical cost for ABSSSI ranged from $8,790-$15,968 for 3 and 7 days IP, 
respectively, while treatment entirely OP to avoid admission ranged from $3692-
$4353. IP medical costs included IP bed-day ($1853) and AE costs ($343). OP care 
included either daily home care ($194) or infusion center fee ($154), PICC line 
with fluoroscopy ($786), PICC complications ($188), labs ($102), and physician 
visit ($222) for evaluation of ABSSSI. IP versus OP cost breakdown was: 3 days IP 
($5,902)/11 days OP ($2,888-$3,429); 7 days IP ($13,314)/7 days OP ($2,273-$2,654). 
Sensitivity analyses revealed OP cost drivers to be IV days, infusion/OP care 
costs, and PICC costs versus LOS, bed-day cost, and IV days for IP drivers. 
CONCLUSIONS: Shifting ABSSSI care to OP settings may result in cost savings up 
to 44%, with potential to prevent HAIs. Typical OP scenarios represent ~33% of 
total medical cost, with PICC accounting for 28-43% of OP burden. Value of new 
ABSSSI therapies will be driven by eliminating need for PICC line and ability to 
reduce/avoid hospital days.  
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A COMPARATIVE ANALYSIS OF CVP STRUCTURE OF NONPROFIT TEACHING 
AND FOR-PROFIT NON-TEACHING HOSPITALS  
Younis M1, Liu LL2, Forgione D3 
1Jackson State University, New Orleans, LA, USA, 2California State University-dominguez hills, 
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Due to the market turbulence facing the hospital industry, the financial viability 
of teaching hospitals has been severely threatened. Their missions of education, 
research, and patient care even strengthen this crisis. Therefore, the objective of 
this study is to conduct a comparative analysis of the cost, volume, and profit 
(CVP) structure between large nonprofit urban teaching hospitals and small for-
profit rural/suburban non-teaching hospitals. The following two hypotheses 
were developed: 1) large nonprofit urban teaching hospitals tend to have higher 
fixed cost, lower variable cost, lower total revenue adjusted by case mix index 
(CMI), and lower return on total assets (ROA), and 2) small for-profit 
rural/suburban non-teaching hospitals tend to have lower fixed cost, higher 
variable cost, higher total revenue adjusted by CMI, and higher ROA. Using 117 
teaching hospitals and 102 non-teaching hospitals selected from the Medicare 
Cost Report database in 2005, the results from multiple regression indicated that 
large nonprofit teaching hospitals located in urban areas are more likely to have 
higher fixed cost and lower variable cost. While such cost structure doesn’t 
necessarily affect their total revenue adjusted by CMI, it does lead to a lower 
return on hospitals’ total assets. The results support our hypotheses in terms of 
fixed cost percentage, variable cost percentage, and ROA, but not total revenue 
adjusted by CMI. The results suggest that cost structure is significantly 
associated with hospitals’ performance. Also, as teaching hospitals’ portfolios of 
services and programs increase (e.g., provision of uncompensated care to 
Medicare and Medicaid patients and doing research), it becomes strategically 
necessary and critical to manage the allocation of resources or investments into 
the fixed capital that supports the business.  
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SUPLEMENTARY HEALTH CARE UTILIZATION RESEARCH IN BRAZIL: 
CHARACTERIZATION OF THE BI.2IM DATABASE  
Araújo GTB1, Abicalaffe CL2, Savian J2, Decimoni TC1, Santos AM1, Fonseca M3 
1Axia.Bio Consulting, São Paulo, Brazil, 22iM S/A, Curitiba, Brazil, 3Federal University of São 
Paulo/Axia.Bio Consulting, São Paulo, Brazil  
OBJECTIVES: The BI.2IM Project started in 2010 to improve costs control and 
register resource utilization of several Brazilian HMOs based on an already 
established (2007) administrative database. The project has evolved in 2011 for 
another utilization related to payment for performance (P4P) and evaluation of 
standard of resource utilization (in-hospital and medical office based data), 
allowing to follow identified patients over prolonged periods of time and to study 
the quantity and cost of health care services provided. Therefore, this 5 million 
lives database (BI.2iM) probabily allows retrospective health care resource 
utilization studies based upon the registered data and their related costs. The 
aim of this study is to verify if BI.2iM database is statistically comparable with 
the total Brazilian Private Healthcare population in terms of regional 
distribuition, gender and age. METHODS: The sample quantity of patients was 
statistically compared with the total private market population in terms of 
regional distribution and gender. Other available information was accessed and 
compared too. RESULTS: The sample compares well to the national private 
market population (sample error of 0,044%) as well as in terms of regional 
distribution. The BI.2iM database can be searched by ICD10 code, Brazilian codes 
for procedures and tests and allows follow up of the patient’s treatment. 
CONCLUSIONS: The BI.2iM sample constitutes a well-characterized supple-
mentary health study population statistically comparable to the national private 
market population. Its results extrapolated to the total supplementary health 
care together with the public health care database (DATASUS) may enable 
evaluation the total Brazilian Healthcare market.  
 
PHS103  
OUTPATIENT VISITS FOR SCHIZOPHRENIA IN THE UNITED STATES: A 
NATIONALLY REPRESENTATIVE ANALYSIS USING NAMCS AND NHAMES DATA  
Stensland MD, Netzer LM 
Agile Outcomes Research, Inc., Rochester, MN, USA  
OBJECTIVES: To characterize the outpatient visits for schizophrenia in the 
United States in comparison to major depressive disorder (MDD) and general 
outpatient (GOP) visits. METHODS: The National Ambulatory Care Survey 
(NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) data 
from 2003 to 2010 were pooled and weighted to provide national level estimates. 
Using ICD-9 codes, visits were classified as schizophrenia (295.xx) or MDD 
(296.2x-296.3x) visits; all others were classified as GOP visits. Estimation methods 
accounting for the surveys’ multistage sampling procedures provided percent-
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ages or means and their 95% confidence intervals. RESULTS: Of the estimated 
8.45 billion outpatient visits in the United States between 2003-2010, 
approximately 22.3 million (0.3%) and 73.6 million (0.9%) were for schizophrenia 
and MDD, respectively. Medicare (35.7% [31.2%-40.4%]) and Medicaid (35.2% 
[31.4%-39.2%]) were most common payers for schizophrenia visits, whereas 
private insurance was most common for MDD (49.6% [46.3%-53.0%]) and GOP 
(52.5% [51.1%-53.9%]) visits. During the previous 12-months, there was a higher 
number of outpatient visits for schizophrenia (11.9 [9.6-14.3]) and MDD (10.9 [9.6-
12.1]) than GOP (4.4 [4.3-4.6]). Primary care physician visits accounted for 17.3% 
[13.4%-22.1%] of schizophrenia, 10.6% [8.2%-13.7%] of MDD, and 46.5% [44.5%-
48.5%] of GOP visits. Psychiatrist visits accounted for 79.7% [73.6%-84.7%] of 
schizophrenia, 89.8% [86.9%-92.1%] of MDD, and 2.0% [1.9%-2.2%] of GOP visits. 
More medications were prescribed at schizophrenia (3.0 [2.8-3.3]) than MDD (2.5 
[2.3-2.6]) or GOP (2.2 [2.1-2.3]) visits. However, medication initiations were less 
frequent at schizophrenia (16.8% [13.6%-20.6%]) and MDD (19.6% [17.3%-22.1%]) 
than GOP (36.4% [35.5%-37.4%]) visits. CONCLUSIONS: The NAMCS and NHAMCS 
data provided a representative characterization of outpatient treatment for 
schizophrenia across different payers in the United States. Outpatient visits for 
schizophrenia differed from MDD or GOP visits across multiple characteristics, 
including payer type, physician specialty, and medication use.  
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EFFECT OF INSURANCE COVERAGE ON HEALTH-CARE EXPENDITURES AMONG 
PATIENTS WITH ARTHRITIS  
Almasri DM, Noor AO, Lai L 
Nova Southeastern University, Ft. Lauderdale, FL, USA  
OBJECTIVES: To compare the effect of insurance coverage on health-care related 
expenditures among patients with arthritis in the United States. METHODS: A 
cross-sectional analysis was conducted. Subjects were derived from the National 
Medical Expenditures Panel Survey (MEPS) for those whom reported having any 
type of arthritis in 2009. A series of weighted univariate statistics were applied to 
examine patient’s demographic characteristics (gender, race, age, etc.) and 
insurance coverage (private, public, and uninsured). We further employed a 
generalized linear regression model to compare the health-care expenditures 
(inpatient, emergency room, outpatient, prescription drug) among different 
insurance status. All analyses utilized SAS PROC SURVEYs’ application to adjust 
for the complex sampling design employed by MEPS database. RESULTS: There 
were an estimated 55.99 million arthritis patients from 2009 MEPS, in which 8.5 
million (15.1%) had rheumatoid arthritis; 21.2 million (37.7%) had osteoarthritis; 
and 26.5 million (47.2%) had unspecified arthritis. It is estimated that the 
majority of the arthritis patients 34.9 million (62.35%) were covered by private 
insurance, 16.5 million (29.5%) were covered by public plans and about 4.5 
million (8%) were uninsured. The total medical expenditure for patients with 
arthritis in 2009 was $522.6 billion. Total prescription expenditures among 
arthritis patients were $122.1 billion. Per capita medical care expenditures 
among private, public and uninsured arthritis patients averaged $8,751, $12,093 
and $3,730 respectively (P<0.0001). Also, there is a significant difference 
(P<0.0001) in the prescription expenditures among private, public and uninsured 
arthritis patients. Average prescription expenditure is $1982.6, $2991.6 and $748 
respectively. CONCLUSIONS: Our findings indicate that uninsured arthritis 
patients had significant lower costs in total health-care expenditure than 
insured patients. Consistently with other studies, the uninsured have more 
unmet health needs than insured Americans. Such undertreated and/or 
underutilized situation may place uninsured people at risk of a serious disability 
complication.  
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IS OBESITY A SIGNIFICANT PREDICTOR OF ASTHMA, ASTHMA RELATED AND 
TOTAL HEALTH CARE COSTS AMONG ELDERLY INDIVIDUALS IN THE UNITED 
STATES?  
Shah R, Yang Y 
University of Mississippi, University, MS, USA  
OBJECTIVES: To investigate whether obesity is associated with asthma, asthma-
related and total direct medical costs in elderly individuals in the U.S. using 
pooled 2006-2010 Medical Expenditure Panel Survey (MEPS) data. METHODS: This 
study is a retrospective analysis of MEPS data from 2006-2010. Individuals 65 
years or older were included in the study. Individuals with asthma were 
identified by ICD-9-CM code 493 or clinical classification code 128. Individuals 
with a self-reported body mass index greater than 30 kg/m2 were considered to 
be obese. A logistic regression model was used to assess the relationship 
between obesity and asthma. Both asthma-related and total direct medical costs 
including inpatient, outpatient, prescription medication and office-based 
physician visit costs were analyzed. All costs were reported in 2010 U.S. dollars,. 
Generalized linear models with gamma distribution and log link were used to 
assess the relationship between obesity and direct medical costs. Individual 
comorbidities and socio-demographic covariates were controlled for in all 
models. All analyses were conducted using SAS while accounting for the 
complex survey design of MEPS. RESULTS: Out of 18,305 elderly individuals in 
MEPS data 2006-2010, 978 were identified as having asthma, of which 595 were 
obese. Obese elderly individuals were more likely to suffer from asthma as 
compared to non-obese individuals (odds ratio: 1.649; 95% Confidence 
Interval:1.306–2.081). Annual asthma-related costs for obese and non-obese 
asthmatic individuals were $1,585.88 (±94.10) and $1,611.83 (±84.65); annual total 
(all-cause) costs for obese and non-obese asthmatic individuals were $16,144 
(±910.63) and $14,525 (±876.79), respectively. The cost analysis results were not 
statistically significant. CONCLUSIONS: Elderly obese individuals are at a great 
risk of suffering from asthma. Although total direct medical cost for obese 
asthmatic elderly individuals were greater than those of non-obese asthmatics, 
obesity is not a statistically significant predictor of asthma-related and total 
direct medical costs among elderly individuals with asthma.  
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GENDER DIFFERENCES IN HEALTH-CARE RELATED EXPENDITURES FOR 
PATIENTS WITH ARTHRITIS IN THE UNITED STATES  
Almasri DM, Lai L 
Nova Southeastern University, Ft. Lauderdale, FL, USA  
OBJECTIVES: Our study aimed to examine gender differences in Health-related 
expenditures for patients with arthritis in the US civilian non-institutionalized 
population. METHODS: A cross-sectional analysis was conducted using the 
National Medical Expenditures Panel Survey data (MEPS). Study subjects included 
patients who reported having any type of arthritis in 2009. The dependent 
variables include total and out of pocket medical expenditures (in-patients, out-
patient, emergency department visits); and total and out of pocket prescription 
drugs expenditures. A series of weighted t-statistics statistics were used to test 
the effect of gender on health-related expenditures. To provide national 
estimates, all analyses incorporated sample weights and standard errors 
corrections to adjust for the complex sampling design employed by MEPS. 
RESULTS: There were an estimated 55.988 million arthritis patients from 2009 
MEPS, in which 8.5 million (15.1%) had rheumatoid arthritis; 21.2 million (37.7%) 
had osteoarthritis; and 26.5 million (47.2%) had unspecified arthritis. About 85% 
of the patients were white and 60.4% were females. Female showed significant 
higher total medical expenditures than male ($9,633 vs. $8,874) (p<0.0001). 
Female also showed significant higher out of pocket medical expenditures than 
male. ($1,337 vs. $1,026) (p<0.0001). The results from prescription total 
expenditures also showed significant difference (p<0.0001) between male ($2,097) 
and female ($2,235) arthritis patients. Finally, the results of out of pocket 
prescription expenditures showed a significant difference (p<0.0001) between 
male ($414) and female ($500). CONCLUSIONS: The study indicates that women 
have higher medical care service utilization and higher associated charges than 
men. The findings provide valuable evidence for future implications of women 
health care services.  
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USING PHONE TRIAGE WITH RISK STRATIFICATION TO INITIATE LOW BACK 
PAIN CARE WITHIN A HEALTH CARE SYSTEM  
Karlen EK 
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OBJECTIVES: Over 50% of people seeking care for low back pain (LBP) enter 
through primary care. Primary care physicians (PCPs) often have less training in 
assessing and treating LBP than physical therapists and medical spine 
specialists. Nationally, the direct cost to manage LBP has continued to grow and 
the outcomes have worsened. This pilot initiated LBP care with the highest-value 
provider type based on the patient’s risk level to determine if higher-value care 
could be delivered. METHODS: For 2 months, patients calling their primary care 
clinic to schedule an appointment for new LBP were diverted to a nurse line. 
After passing a red-flag screen, the patients were risk stratified using the Keele 
STarT Back tool. Low and medium risk patients immediately received reassure-
ance and education in self-management. Those still wanting to see a clinician 
scheduled with a physical therapist. High risk patients scheduled with medical 
spine specialists. Patients referred to physical therapy were matched to 
therapists capable of delivering evidence-based care for their specific risk level. 
Physical therapists received best-practice guidelines and patient profiles for each 
of the risk levels. Patient improvement was measured with the Oswestry 
Disability Index (ODI). RESULTS: Of the 42 LBP patients referred to physical 
therapy, 90% were matched to physical therapists based on risk level. The 
cumulative average ODI improvement was 39% in 5.5 visits, a .06 QALY 
improvement over the previous care model that delivered an average ODI 
improvement of 27% in 6 visits. Patients receiving care from a medical spine 
specialist were 56% more likely to have appropriate imaging and 50 times less 
likely to be prescribed opioids. Estimated direct medical costs savings were 15-
31% with 41-61% in total cost savings to the community. CONCLUSIONS: Phone 
triaging that includes risk stratification delivers higher-value LBP care than 
traditional care models.  
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A QUALITATIVE EXPLORATION OF PERCEPTIONS TOWARDS 
PHARMACEUTICAL PRICE WAR AMONG COMMUNITY PHARMACIES IN  
THE STATE OF PENANG, MALAYSIA  
Tan CS, Hassali MA, Saleem F 
Universiti Sains Malaysia, Penang, Malaysia  
OBJECTIVES: To evaluate perceptions of community pharmacists towards medi-
cine pricing issues in the model of practice in Malaysia. METHODS: A qualitative 
approach was adopted. Semi structured interviews were conducted by face to 
face interview. Purposive sampling technique was used to recruit a convenient 
sample of full time community pharmacists practising in the State of Penang, 
Malaysia. All interviews were audio recorded, transcribed verbatim and 
thematically analysed. RESULTS: A total of 11 community pharmacists were 
recruited in this study. Thematic content analysis of the interviews identified 
three main themes: factors causing pharmaceutical price war, potential impact 
of price war, and recommendations to overcome price war. In general, price war 
phenomenon has diminished the profit margin of community pharmacists and 
threatened their survival. Thus the participants were anticipated government 
could control medicine price. The findings in this study also highlighted 
participants were dissatisfied with the unethical practise by pharmaceutical 
company in offering different bonus schemes. The bonus schemes also reported 
as discriminatory as physician were offered better perks compare to community 
